161 related articles for article (PubMed ID: 26486743)
1. Utility of BRAF V600E mutation-specific immunohistochemistry in detecting BRAF V600E-mutated gastrointestinal stromal tumors.
Patil DT; Ma S; Konishi M; Carver PD; Pukay M; Beadling C; Corless CL; Rubin BP
Am J Clin Pathol; 2015 Nov; 144(5):782-9. PubMed ID: 26486743
[TBL] [Abstract][Full Text] [Related]
2. [Application of BRAF V600E mutation-specific immunohistochemistry in diagnosis of gastrointestinal stromal tumors].
Shi SS; Wang X; Xia QY; Lu ZF; Ye SB; Yang WR; Li R; Ma HH; Rao Q; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):566-70. PubMed ID: 27510784
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
4. BRAF mutations in KIT/PDGFRA positive gastrointestinal stromal tumours (GISTs): Is their frequency underestimated?
Jašek K; Váňová B; Grendár M; Štanclová A; Szépe P; Hornáková A; Holubeková V; Plank L; Lasabová Z
Pathol Res Pract; 2020 Nov; 216(11):153171. PubMed ID: 32836055
[TBL] [Abstract][Full Text] [Related]
5. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP
J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230
[TBL] [Abstract][Full Text] [Related]
6. P16 overexpression in BRAF-mutated gastrointestinal stromal tumors.
Shi SS; Wang X; Xia QY; Rao Q; Shen Q; Ye SB; Li R; Shi QL; Lu ZF; Ma HH; Zhou XJ
Expert Rev Mol Diagn; 2017 Feb; 17(2):195-201. PubMed ID: 28034324
[TBL] [Abstract][Full Text] [Related]
7. No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibody.
Preusser M; Berghoff AS; Capper D; von Deimling A; Maroske F; Brodowicz T; Hejna M; Birner P; Schoppmann SF
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):426-30. PubMed ID: 23343956
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumours.
Wong NA; Wingate J; Gradhand E
Histopathology; 2015 Sep; 67(3):378-85. PubMed ID: 25659413
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization.
Kuan SF; Navina S; Cressman KL; Pai RK
Hum Pathol; 2014 Mar; 45(3):464-72. PubMed ID: 24529329
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.
Dvorak K; Higgins A; Palting J; Cohen M; Brunhoeber P
Pathol Oncol Res; 2019 Jan; 25(1):349-359. PubMed ID: 29127628
[TBL] [Abstract][Full Text] [Related]
11. A smooth muscle-derived, Braf-driven mouse model of gastrointestinal stromal tumor (GIST): evidence for an alternative GIST cell-of-origin.
Kondo J; Huh WJ; Franklin JL; Heinrich MC; Rubin BP; Coffey RJ
J Pathol; 2020 Dec; 252(4):441-450. PubMed ID: 32944951
[TBL] [Abstract][Full Text] [Related]
12. Multiple sporadic gastrointestinal stromal tumours arising at different gastrointestinal sites: pattern of involvement of the muscularis propria as a clue to independent primary GISTs.
Agaimy A; Märkl B; Arnholdt H; Wünsch PH; Terracciano LM; Dirnhofer S; Hartmann A; Tornillo L; Bihl MP
Virchows Arch; 2009 Aug; 455(2):101-8. PubMed ID: 19572146
[TBL] [Abstract][Full Text] [Related]
13. Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.
Bösmüller H; Fischer A; Pham DL; Fehm T; Capper D; von Deimling A; Bonzheim I; Staebler A; Fend F
Hum Pathol; 2013 Mar; 44(3):329-35. PubMed ID: 23089489
[TBL] [Abstract][Full Text] [Related]
14. BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma.
Affolter K; Samowitz W; Tripp S; Bronner MP
Genes Chromosomes Cancer; 2013 Aug; 52(8):748-52. PubMed ID: 23650027
[TBL] [Abstract][Full Text] [Related]
15. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.
Capper D; Preusser M; Habel A; Sahm F; Ackermann U; Schindler G; Pusch S; Mechtersheimer G; Zentgraf H; von Deimling A
Acta Neuropathol; 2011 Jul; 122(1):11-9. PubMed ID: 21638088
[TBL] [Abstract][Full Text] [Related]
16. Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma.
Tetzlaff MT; Pattanaprichakul P; Wargo J; Fox PS; Patel KP; Estrella JS; Broaddus RR; Williams MD; Davies MA; Routbort MJ; Lazar AJ; Woodman SE; Hwu WJ; Gershenwald JE; Prieto VG; Torres-Cabala CA; Curry JL
Hum Pathol; 2015 Aug; 46(8):1101-10. PubMed ID: 26058727
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutation status in gastrointestinal stromal tumors.
Hostein I; Faur N; Primois C; Boury F; Denard J; Emile JF; Bringuier PP; Scoazec JY; Coindre JM
Am J Clin Pathol; 2010 Jan; 133(1):141-8. PubMed ID: 20023270
[TBL] [Abstract][Full Text] [Related]
19. BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer.
Ilie MI; Long-Mira E; Hofman V; Mouroux J; Vignaud JM; Gauchotte G; Begueret H; Merlio JP; Emile JF; Hébuterne X; Hofman P
Pathology; 2014 Jun; 46(4):311-5. PubMed ID: 24798160
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
Long GV; Wilmott JS; Capper D; Preusser M; Zhang YE; Thompson JF; Kefford RF; von Deimling A; Scolyer RA
Am J Surg Pathol; 2013 Jan; 37(1):61-5. PubMed ID: 23026937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
